If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

Share Price is delayed by 15 minutes
Get Live Data
177.50    2.50 (1.43%)
Bid:
175.00
Ask:
180.00
Spread: 5.00 (2.857%)
Market Cap: £9.79m
TND Live PriceLast checked at - London Stock Exchange

Intraday Tandem Group Share Chart

Grant of Share Options

29 Apr 2021 07:00

RNS Number : 9881W
Tandem Group PLC
29 April 2021
 

Tandem Group plc

(the "Company")

 

Grant of Share Options

 

The Company announces that Jim Shears and Phil Ratcliffe, Directors of the Company, have been granted 24,000 and 13,000 options ("Options") respectively over ordinary shares of 25 pence each in the share capital of the Company ("Ordinary Shares") under the 2019 Employee Share Option Scheme.

 

The Options have an exercise price of 665.00 pence per ordinary share, being the closing midmarket price per ordinary share on 28 April 2021. The Options are exercisable between 1 January 2024 and 28 April 2031, after which the Options will lapse. The exercise of the Options

is conditional on certain performance criteria being met.

 

A further 40,000 options have been granted to other employees under the 2019 Employee Share Option Scheme.

 

Following the above transactions, the Directors have options over Ordinary Shares as follows:

 

Director

Option Scheme

Number of options

Option exercise price per share

Expiry date

Steve Grant

2019 Employee Share Option Scheme

50,000

190.00p

24 May 2029

2007 Employee Share Option Scheme

75,000

127.50p

20 April 2026

Jim Shears

2019 Employee Share Option Scheme

24,000

665.00p

28 April 2031

2019 Employee Share Option Scheme

44,278

190.00p

24 May 2029

Phil Ratcliffe

2019 Employee Share Option Scheme

13,000

665.00p

28 April 2031

2019 Employee Share Option Scheme

45,000

190.00p

24 May 2029

2007 Employee Share Option Scheme

58,897

127.50p

20 April 2026

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Jim Shears

2

Reason for notification

 

 

 

a.

Position/Status

CEO

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Tandem Group plc

b.

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Options over ordinary Shares of 25p eachISIN: GB00B460T373

b.

Nature of the transaction

Grant of options

c.

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

665p

24,000

 

 

 

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

 

24,000

 

665p

e.

Date of the transaction

28 April 2021

f.

Place of the transaction

(London) AIM

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Philip Ratcliffe

2

Reason for notification

 

 

 

a.

Position/Status

Commercial Director

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Tandem Group plc

b.

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Options over ordinary Shares of 25p eachISIN: GB00B460T373

b.

Nature of the transaction

Grant of options

c.

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

665p

13,000

 

 

 

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

 

13,000

 

665p

e.

Date of the transaction

28 April 2021

f.

Place of the transaction

(London) AIM

 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company take responsibility for this announcement.

 

Enquiries:

 

Tandem Group plc

Jim Shears, Chief Executive Officer

David Rock, Company Secretary

Telephone 0121 748 8075

 

Nominated Adviser

Cairn Financial Advisers LLP

James Caithie

Sandy Jamieson

Telephone 020 7213 0880

 

29 April 2021

 

Forward-Looking Statements

 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBCGDSCUDDGBI
Date   Source Headline
23rd Jun 20268:34 amRNSDirector/PDMR Shareholding
22nd Jun 20261:18 pmRNSHolding(s) in Company
19th Jun 202612:00 pmRNSHolding(s) in Company
17th Jun 20264:01 pmRNSResult of AGM
17th Jun 20267:00 amRNSAGM Trading Statement
23rd Mar 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSTrading Update and Notice of Results
20th Oct 202512:24 pmRNSDirector/PDMR Shareholding
14th Oct 202511:53 amRNSDirector/PDMR Shareholding
6th Oct 202511:56 amRNSDirector/PDMR Shareholding
29th Sep 20259:28 amRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSInterim Results
2nd Jul 20252:06 pmRNSDirector/PDMR Shareholding
1st Jul 20253:57 pmRNSDirector/PDMR Shareholding
24th Jun 20252:22 pmRNSResult of Annual General Meeting
24th Jun 20257:00 amRNSAGM Trading Statement
2nd Jun 20257:00 amRNSTotal Voting Rights
8th Apr 20255:45 pmRNSGrant of Options & Surrender of Existing Options
7th Apr 202511:30 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSFinal Results
11th Mar 20257:00 amRNS-RExclusive Partnership for New Bike Range
5th Feb 20257:00 amRNSTrading Update and Notice of Results
31st Jan 20257:00 amRNSDirectorate Changes
17th Oct 202411:15 amRNSDirectorate Change and Relationship Agreement
19th Sep 20247:00 amRNSHalf-year Report
31st Jul 20249:14 amRNSHolding(s) in Company
23rd Jul 20243:55 pmRNSAppointment of Chief Financial Officer
26th Jun 202412:29 pmRNSResult of AGM
26th Jun 20247:00 amRNSAGM Statement
27th Mar 20244:36 pmRNSGrant of Share Options
25th Mar 20247:00 amRNSFinal Results
27th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20243:31 pmRNSGrant of Share Options
5th Feb 20245:15 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSTrading Update and Notice of Results
10th Jan 202411:27 amRNSHolding(s) in Company
13th Dec 20232:19 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSTrading Update
6th Nov 202311:51 amRNSChange of Nominated Adviser and Broker
29th Sep 202310:36 amRNSDirector/PDMR Shareholding
25th Sep 202311:07 amRNSHolding(s) in Company
21st Sep 20234:42 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSHalf Yearly Report
29th Jun 20234:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
11th May 20234:44 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:20 pmRNSPDMR Transaction
28th Mar 20235:09 pmRNSGrant of share options
27th Mar 20237:00 amRNSFinal Results
24th Feb 202312:36 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.